Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Company Profile F3 Platform Biologics Inc JDRR

F3 Platform Biologics, Inc. is a United States-based biopharmaceutical company. The Company is focused on the research, clinical development, and ultimate commercialization of amifostine. Amifostine repair and protects against human cell mutation and destruction, as well as radiation-induced genomic damage and instability (RIGDI), a precursor to carcinogenesis, which occurs when human cells are... see more

Showcase News Releases

Showcase news

Nanalysis Scientific Corp.
Nanalysis Announces Third Quarter 2024 Results
Bank of Montreal
BMO Among Canada's Most Admired Corporate Cultures (TM): Waterstone Human Capital
Globex Mining Enterprises Inc.
O3 Mining Starts Drilling on Globex's Florence and Cameron Royalty Claims

More Showcase News Releases »